A TREATMENT ALGORITHM FOR CHILDREN WITH LUPUS NEPHRITIS TO PREVENT DEVELOPING RENAL FAILURE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HAJIZADEH NILOOFAR; JAVADI LAIJANI FAEZEH; MOGHTADERI MASTANEH; ATAEI NEAMATOLLAH; ASADI FARAHNAK

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Preventive Medicine Year:2014 | Volume:5 | Issue:3 Page(s): 250-255

Download Full-Text

View:

293

Download:

117

Cites:

Information Journal Paper

Title

A TREATMENT ALGORITHM FOR CHILDREN WITH LUPUS NEPHRITIS TO PREVENT DEVELOPING RENAL FAILURE

Author(s)

Keywords

END-STAGE RENAL DISEASE

LUPUS

NEPHRITIS

TREATMENT ALGORITHM

Abstract

Chronic kidney disease is one of the most common complication of systemic LUPUS erythematous, which if untreated can lead to the END-STAGE RENAL DISEASE (ESRD). Early diagnosis and adequate treatment of LUPUS NEPHRITIS (LN) is critical to prevent the chronic kidney disease incidence and to reduce the development of ESRD. The treatment of LN has changed significantly over the past decade. In patients with active proliferative LN (Classes III and IV) intravenous methylprednisolone 1 g/m2 /day for 1-3 days then prednisone 0.5-1.0 mg/kg/day, tapered to <0.5 mg/kg/day after 10-12 weeks of treatment plus mycophenolate mofetile (MMF) 1.2 g/m2 /day for 6 months followed by maintenance lower doses of MMF 1-2 g/day or azathioprine (AZA) 2 mg/kg/day for 3 years have proven to be efficacy and less toxic than cyclophosphamide (CYC) therapy. Patients with membranous LN (Class V) plus diffuse or local proliferative LN (Class III and Class IV) should receive either the standard 6 monthly pulses of CYC (0.5-1 g/m2 /month) then every 3 rd month or to a shorter treatment course consisting of 0.5 g/m2 IV CYC every 2 weeks for six doses (total dose 3 g) followed by maintenance therapy with daily AZA (2 mg/kg/day) or MMF (0.6 g/m2 /day) for 3 years. Combination of MMF plus rituximab or MMF plus calcineurin inhibitors may be an effective co-therapy for those refractory to induction or maintenance therapies. This report introduces a new TREATMENT ALGORITHM to prevent the development of ESRD in children with LN.

Cites

No record.

References

No record.

Cite

APA: Copy

HAJIZADEH, NILOOFAR, JAVADI LAIJANI, FAEZEH, MOGHTADERI, MASTANEH, ATAEI, NEAMATOLLAH, & ASADI, FARAHNAK. (2014). A TREATMENT ALGORITHM FOR CHILDREN WITH LUPUS NEPHRITIS TO PREVENT DEVELOPING RENAL FAILURE. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 5(3), 250-255. SID. https://sid.ir/paper/316056/en

Vancouver: Copy

HAJIZADEH NILOOFAR, JAVADI LAIJANI FAEZEH, MOGHTADERI MASTANEH, ATAEI NEAMATOLLAH, ASADI FARAHNAK. A TREATMENT ALGORITHM FOR CHILDREN WITH LUPUS NEPHRITIS TO PREVENT DEVELOPING RENAL FAILURE. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE[Internet]. 2014;5(3):250-255. Available from: https://sid.ir/paper/316056/en

IEEE: Copy

NILOOFAR HAJIZADEH, FAEZEH JAVADI LAIJANI, MASTANEH MOGHTADERI, NEAMATOLLAH ATAEI, and FARAHNAK ASADI, “A TREATMENT ALGORITHM FOR CHILDREN WITH LUPUS NEPHRITIS TO PREVENT DEVELOPING RENAL FAILURE,” INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, vol. 5, no. 3, pp. 250–255, 2014, [Online]. Available: https://sid.ir/paper/316056/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops